Literature DB >> 17143005

Barriers to stroke thrombolysis in a geographically defined population.

S T Engelter1, M Gostynski, S Papa, V Ajdacic-Gross, P A Lyrer.   

Abstract

OBJECTIVE: Barriers to thrombolysis are rather assessed for hospitalized stroke patients than among geographically defined populations. In a population-based approach, we assessed (1) the utilization rate of stroke thrombolysis in the community, and (2) the significance of the chosen stroke care provider as a potential barrier to thrombolysis.
METHODS: We performed a databank-based post-hoc analysis, derived from data ascertained in a prospective, population-based stroke study among the permanent residents of the canton Basel-City, Switzerland. For the cohort with an onset assessment interval (OAI) < or =3 h, we compared thrombolyzed with non-thrombolyzed patients concerning demographic variables, the National Institutes of Health stroke scale (NIHSS) score, OAI, risk factors, and the type of stroke care provider. For patients without thrombolysis despite an OAI < or =3 h, barriers to thrombolysis were compiled.
RESULTS: Among 269 patients, 49 had an OAI < or =3 h (18% of all patients and 38% of those 128 patients with exactly known time of onset). Fourteen patients received thrombolysis, amounting to a utilization rate of 5.2% (95% CI 2.9-8.6) for all patients and 29% (95% CI 17-43) for the OAI < or =3-hour cohort. For the latter, thrombolyzed differed from non-thrombolyzed patients in higher NIHSS score and type of stroke care provider, but not in demographic variables, OAI, or risk factors. Fourteen of 40 patients (35%) primarily admitted to the stroke unit received thrombolysis, compared with none of 9 patients primarily treated elsewhere (p < 0.04). In the OAI < or =3-hour cohort, mild or regressing stroke severity (48%), admission to hospitals not offering thrombolysis (20%), computed tomography or laboratory contraindications (17%) and severe comorbidity (14%) were barriers to thrombolysis.
CONCLUSION: In this geographically defined population, every 20th stroke patient received thrombolysis. Only a minority of patients had an OAI < or =3 h, rendering late admission the most common barrier to thrombolysis. In the OAI < or =3-hour cohort, admission to hospitals not offering thrombolysis prompted exclusion from thrombolysis as often as established contraindications. Thus, acute stroke patients should solely be brought to hospitals providing thrombolysis.

Entities:  

Mesh:

Year:  2006        PMID: 17143005     DOI: 10.1159/000097643

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  8 in total

1.  No-go to tissue plasminogen activator for transient ischemic attack.

Authors:  David S Liebeskind
Journal:  Stroke       Date:  2010-10-28       Impact factor: 7.914

Review 2.  Reducing prehospital delay in acute stroke.

Authors:  Miriam Bouckaert; Robin Lemmens; Vincent Thijs
Journal:  Nat Rev Neurol       Date:  2009-08-11       Impact factor: 42.937

3.  Use of telemedicine and other strategies to increase the number of patients that may be treated with intravenous thrombolysis.

Authors:  Gisele Sampaio Silva; Lee H Schwamm
Journal:  Curr Neurol Neurosci Rep       Date:  2012-02       Impact factor: 5.081

4.  [Ten years' experience at a major stroke center].

Authors:  T Konatschnig; A Knöll; A Hug; W Hacke; P Ringleb
Journal:  Nervenarzt       Date:  2009-02       Impact factor: 1.214

Review 5.  Review, historical context, and clarifications of the NINDS rt-PA stroke trials exclusion criteria: Part 1: rapidly improving stroke symptoms.

Authors:  Steven R Levine; Pooja Khatri; Joseph P Broderick; James C Grotta; Scott E Kasner; Doojin Kim; Brett C Meyer; Peter Panagos; Jose Romano; Phillip Scott
Journal:  Stroke       Date:  2013-07-11       Impact factor: 7.914

Review 6.  How can we improve stroke thrombolysis rates? A review of health system factors and approaches associated with thrombolysis administration rates in acute stroke care.

Authors:  Christine L Paul; Annika Ryan; Shiho Rose; John R Attia; Erin Kerr; Claudia Koller; Christopher R Levi
Journal:  Implement Sci       Date:  2016-04-08       Impact factor: 7.327

7.  Reasons and evolution of non-thrombolysis in acute ischaemic stroke.

Authors:  T Reiff; P Michel
Journal:  Emerg Med J       Date:  2016-10-25       Impact factor: 2.740

8.  GRP per capita and hospital characteristics associated with intravenous tissue plasminogen activator adherence rate: evidence from the Chinese Stroke Center Alliance.

Authors:  Suxi Zheng; Tian Jie Lyu; Zixiao Li; Hongqiu Gu; Xin Yang; Chunjuan Wang; Hao Li; Yong Jiang; Haipeng Shen; Yongjun Wang
Journal:  Stroke Vasc Neurol       Date:  2021-01-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.